T. Rowe Price Investment Management
NRIX icon

T. Rowe Price Investment Management’s Nurix Therapeutics NRIX Stock Holding History

T. Rowe Price Investment Management’s Portfolio NRIX Stock Details NRIX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$11.1M Sell
2025
Q2 		$28.2M Buy
2025
Q1 		$28.8M Buy
2024
Q4 		$44.8M Sell
2024
Q3 		$57.3M Buy
2024
Q2 		$45.7M Buy
2023
Q1 		– Sell
2022
Q4 		$4.75M Sell
2022
Q3 		$12.9M Buy